• EZ Cap™ Human PTEN mRNA (ψUTP) Workflow

  2026-09-10

  Use EZ Cap™ Human PTEN mRNA (ψUTP) to restore transient PTEN expression in mammalian models and interrogate PI3K/Akt-driven resistance. Its Cap1, pseudouridine-modified design supports a practical workflow spanning cell-based cancer research, pathway studies, and nanoparticle-enabled delivery experiments.

• BCA Protein Assay Kit: Principles and Workflow

  2026-09-10

  The BCA Protein Assay Kit provides bicinchoninic acid protein quantification through a copper-reduction reaction measured at 562 nm. Its stated 50–2000 μg/mL linear range, 0.5 μg minimum protein detection limit, and low sample requirement support reproducible protein concentration measurement in molecular biology workflows.

• S-Adenosylmethionine (SAM) Assay Workflows

  2026-09-09

  Build more interpretable methylation assays with Ademetionine by controlling concentration, matrix, storage, and reaction timing. This practical guide connects S-adenosylmethionine workflows to epigenetic, metabolic, and neurological research without confusing biochemical activity with clinical efficacy.

• Bay 11-7085: A Mechanistic Assay Compass

  2026-09-09

  Bay 11-7085 is an NF-κB activation inhibitor that connects inflammatory signaling with cell-cycle and apoptosis phenotypes. This guide uses recent ER stress–NF-κB research to show how to interpret the probe across disease-relevant assays without overclaiming pathway specificity.

• HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit

  2026-09-08

  This scenario-driven guide explains how HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit (SKU K1062) can support fluorescent RNA probe synthesis alongside cell viability, proliferation, and cytotoxicity workflows. It covers probe design, T7 transcription, Cy5-UTP optimization, interpretation, and practical product-selection criteria.

• Gramine and the CUL3–MTDH Ferroptosis Axis

  2026-09-07

  Gramine is emerging as a mechanistically informative ferroptosis inducer for triple-negative breast cancer research. This article interprets the CUL3–MTDH ubiquitination mechanism, translates the evidence into experimental planning, and defines the opportunities and limitations that matter for translational cancer biology programs.

• DHEA Workflows for PCOS and Neuroprotection

  2026-09-07

  Dehydroepiandrosterone (DHEA) can model inflammatory ovarian dysfunction while also serving as a neuroprotection agent in carefully controlled neural assays. This guide connects dose selection, conditioned-medium experiments, granulosa cell biology, and hippocampal neuron protection with practical troubleshooting.

• ECL Western Blotting Substrate: Workflow Guide

  2026-09-05

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for visualizing HRP-labeled proteins on immunoblots. It supports protein detection by chemiluminescence with X-ray film or CCD cameras, but it should not replace fluorescent or radioisotopic detection reagents.

• ATRX Loss Sensitizes Glioma Cells to PDGFR Inhibition

  2026-09-05

  The 2022 Cancers study identified ATRX deficiency as a potential biomarker of increased sensitivity to selected receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination experiments further suggest that ATRX status may help interpret RTK inhibitor trials and guide combinations with temozolomide.

• Phosbind Biotin for Phosphoprotein Detection

  2026-09-04

  Phosbind Biotin enables sequence-independent detection of phosphorylated proteins on PVDF membranes. This guide connects its dinuclear metal complex phosphate binding chemistry with practical protein phosphorylation analysis and the PtrbZIP12 drought-response study.

• Ibrexafungerp: Applied Antifungal Workflows

  2026-09-04

  Ibrexafungerp, also known as MK 3118, combines oral delivery with a distinct glucan synthase-binding profile that is useful for resistant Candida research. This guide converts supporting in vitro and murine evidence into practical susceptibility, acidic-pH, infection-model, and troubleshooting workflows.

• ARID1A-Dependent Resistance in Melanoma Multi-Omics

  2026-09-03

  The reference study integrates signaling, proteomic, and transcriptional evidence to define how ARID1A loss rewires early responses to BRAF/MAPK inhibition in melanoma. Its identification of PRKD1, JUN, and NCK1 as resistance-associated network nodes provides a systems-level framework for studying persistent MAPK activity, immune-evasion features, and treatment adaptation.

• EZ Cap™ Human PTEN mRNA: Assay Design Guide

  2026-09-02

  EZ Cap™ Human PTEN mRNA (ψUTP) enables controlled, transient PTEN restoration for mechanistic cancer research. This guide focuses on assay architecture, delivery-aware controls, and how to interpret PI3K/Akt responses without confusing payload activity with nanoparticle performance.

• Bovine Insulin in Glioblastoma Senescence Assays

  2026-09-02

  Bovine insulin can serve as both a growth factor supplement for cultured cells and a controlled metabolic variable in delayed drug-response studies. This workflow connects insulin-supported culture quality with the reference study’s senescence-focused glioblastoma assay design, while emphasizing vehicle controls, solubility, and time-resolved readouts.

• Bufalin N1507: Reliable Cell Assay Workflows

  2026-09-02

  Learn how Bufalin (SKU N1507) can improve the interpretation and reproducibility of cell viability, proliferation, and cytotoxicity experiments. This scenario-based guide covers solvent compatibility, assay optimization, mechanistic interpretation, and practical product-selection criteria for oncology research.

8649 records 1/577 page Next 12345 下5页 Last page